Attached files
file | filename |
---|---|
10-K/A - FORM 10-K/A - PLUS THERAPEUTICS, INC. | form10ka.htm |
EX-32.1 - EXHIBIT 32.1 - PLUS THERAPEUTICS, INC. | ex32_1.htm |
EX-31.2 - EXHIBIT 31.2 - PLUS THERAPEUTICS, INC. | ex31_2.htm |
EXHIBIT 31.1
Certification of Principal Executive Officer Pursuant to
Securities Exchange Act Rule 13a-14(a)
As Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
Securities Exchange Act Rule 13a-14(a)
As Adopted Pursuant to
Section 302 of the Sarbanes-Oxley Act of 2002
I, Marc H. Hedrick, certify that:
1.
|
I have reviewed this Amendment No. 1 to Annual Report on Form 10-K of Cytori Therapeutics, Inc.;
|
2.
|
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report.
|
Date: March 24, 2016
|
|
/s/ Marc H. Hedrick, MD
|
|
Marc H. Hedrick,
|
|
President & Chief Executive Officer
|